K Number
K042084
Device Name
BIODERM SCIENCES WOUND HEALING SPRAY
Date Cleared
2005-06-15

(316 days)

Product Code
Regulation Number
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
BioDerm Sciences Wound Spray is intended to cleanse, rinsc and externally manage dermal lesions such as lacerations, post-operative (surgical) wounds, partial and full-thickness wounds, burns and ulcers (diabetic, venous stasis, pressure). It may also be used in conjunction with a dressing that absorbs fluids (i.e. gauze, gel, alginate, foam, hydrocolloid). BioDerm Sciences Wound Spray is intended to clean, rinse and externally manage skin wounds such as minor lacerations, minor cuts, minor burns and abrasions.
Device Description
BioDerm Wound Spray is an acidic zinc-saline wet dressing for external wound management. It aids the body in the healing process by providing a moist, acidic wound environment. The non-irritating components of BioDerm Wound Spray allow it to be used in the mouth, eyes and on mucous membrancs as well as on the skin. BioDerm Wound Spray is similar in chemical composition to the previously cleared BioDerm Scicnces Wound Solution with the spray also containing 0.002% of some trace elements. A difference between these products is that the predicate device BioDerm Scicnccs Wound Solution is supplied sterile in injection bottles, while the current device is supplied non-sterile in pump-spray bottles. The dressing is applied by spraying onto the affected arca. BioDerm Wound Spray is supplied in 100 ml spray bottles with a plunger activated pump applicator.
More Information

Not Found

No
The device description and intended use focus on the chemical composition and physical application of a wound spray, with no mention of AI or ML capabilities.

Yes

Explanation: The device is intended to cleanse, rinse, and externally manage dermal lesions and skin wounds, and aids the body in the healing process, which are therapeutic functions.

No

The device is described as an "acidic zinc-saline wet dressing for external wound management" that "aids the body in the healing process by providing a moist, acidic wound environment." Its intended use is to "cleanse, rinse and externally manage dermal lesions" and "clean, rinse and externally manage skin wounds." These functions are therapeutic and management-oriented, not diagnostic. There is no mention of the device being used to identify, detect, or characterize a disease or condition.

No

The device description clearly indicates it is a physical wound spray supplied in bottles with a pump applicator, not a software product.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is to cleanse, rinse, and externally manage dermal lesions and skin wounds. This is a direct application to the body for therapeutic or management purposes.
  • Device Description: The device is a wound spray applied externally to the affected area.
  • Lack of In Vitro Testing: There is no mention of the device being used to test samples in vitro (outside of the body) to diagnose or provide information about a patient's condition. The performance study mentioned uses a porcine model, which is an in vivo (in a living organism) study.

IVD devices are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening. This device does not fit that description.

N/A

Intended Use / Indications for Use

BioDerm Sciences Wound Spray is intended to cleanse, rinsc and externally manage dermal lesions such as lacerations, post-operative (surgical) wounds, partial and full-thickness wounds, burns and ulcers (diabetic, venous stasis, pressure). It may also be used in conjunction with a dressing that absorbs fluids (i.e. gauze, gel, alginate, foam, hydrocolloid).

BioDerm Sciences Wound Spray is intended to clean, rinse and externally manage skin wounds such as minor lacerations, minor cuts, minor burns and abrasions.

Product codes

FRO

Device Description

BioDerm Wound Spray is an acidic zinc-saline wet dressing for external wound management. It aids the body in the healing process by providing a moist, acidic wound environment. The non-irritating components of BioDerm Wound Spray allow it to be used in the mouth, eyes and on mucous membrancs as well as on the skin.

BioDerm Wound Spray is similar in chemical composition to the previously cleared BioDerm Scicnces Wound Solution with the spray also containing 0.002% of some trace elements. A difference between these products is that the predicate device BioDerm Scicnccs Wound Solution is supplied sterile in injection bottles, while the current device is supplied non-sterile in pump-spray bottles. The dressing is applied by spraying onto the affected arca.

BioDerm Wound Spray is supplied in 100 ml spray bottles with a plunger activated pump applicator.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Dermal lesions, skin wounds, mouth, eyes, mucous membranes

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

A study of various formulations with varying strength levels of the metallic salts, performed at the University of Miami (Department of Dermatology & Cutaneous Surgery) using a porcine model demonstrated the effectiveness of BioDerm Wound Spray as an aid to the body's healing of burns, and partial wounds.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K040683, K945802, K040779

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

N/A

0

042084

JUN 1 5 2005

510(k) summary as described in § 807.92

510(k) Summary

Submitter:BioDerm Sciences, Inc.
Enterprise Center
9 Industrial Park Drive, Suite 1N
Oxford, Mississippi 38655
Phone: (301) 216-3912
Contact Person:Ed Gubish Ph. D.
Chief Scientific Officer
Preparation Date:May 26, 2005
Proprietary Device Name:BioDerm Wound Spray
Classification Name:Liquid Bandage
Predicate Devices:

BioDerm Wound Solution Dermagran wound cleanser with zinc Restore Wound Cleanser

K040683 K945802 K040779

Description:

BioDerm Wound Spray is an acidic zinc-saline wet dressing for external wound management. It aids the body in the healing process by providing a moist, acidic wound environment. The non-irritating components of BioDerm Wound Spray allow it to be used in the mouth, eyes and on mucous membrancs as well as on the skin.

BioDerm Wound Spray is similar in chemical composition to the previously cleared BioDerm Scicnces Wound Solution with the spray also containing 0.002% of some trace elements. A difference between these products is that the predicate device BioDerm Scicnccs Wound Solution is supplied sterile in injection bottles, while the current device is supplied non-sterile in pump-spray bottles. The dressing is applied by spraying onto the affected arca.

BioDerm Wound Spray is supplied in 100 ml spray bottles with a plunger activated pump applicator.

Intended Use (Prescription):

BioDerm Sciences Wound Spray is intended to cleanse, rinse and externally manage dermal lesions such as lacerations, post-operative (surgical) wounds, partial

Confidential BioDerm Sciences, Inc.

1

and full-thickness wounds, burns and ulcers (diabetic, venous stasis, pressure). It is and thickness wounds, carrior with a sterile dressing that absorbs fluids (i.e. gauze, gel, alginate, foam, hydrocolloid).

Intended Use (OTC): BioDerm Sciences Wound Spray is intended to clean, rinse mendou Ose (Oren Blow wounds such as minor lacerations, minor cuts, minor cuts, minor burns and abrasions.

BioDerm Wound Spray can also be used as a wound cleanser to remove foreign matter, bacteria and tissue debris.

BioDerm Wound Spray is contraindicated for use when patients are known to have had allergic reactions to this dressing or its components. It is not suitable for use on third degree aners, or for any wound for which the dermis has been severcly damaged or is missing.

Comparison of Technological Characteristics:

A number of wet dressings have been cleared for marketing by the FDA. All have in A numor of we we a caline solutions based on sodium chloride or metallic salts with a pH less than or equal to 7 (i.e. acidic). They may or may not contain additives such as nutrients. BioDerm Wound Spray is supplied non-sterile.

A broad range of chemical compositions is currently available. The chemical composition of BioDerm Wound Spray is within the range of chemical compositions of these predicate devices and is substantially equivalent in terms of its safety and effectiveness. (Sec Table 1)

Performance:

A study of various formulations with varying strength levels of the metallic salts, performed at the University of Miami (Department of Dermatology & Cutaneous Surgery) using a porcine model demonstrated the effectiveness of BioDerm Wound Spray as an aid to the body's healing of burns, and partial wounds.

Conclusions:

When used as directed, BioDerm Wound Spray is safe and offective as a wound cleanser or wet dressing.

2

Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features the department's name in a circular arrangement around a stylized symbol. The symbol consists of three abstract human profiles facing to the right, stacked on top of each other.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAY - 1 2007

Edward R. Gubish, Ph.D. Chief Scientific Officer BioDerm Sciences Inc. Enterprise Center 9 Industrial Park Drive, Suite 1N Oxford, Mississippi 38665

K042084 Re: Trade Name: BioDerm Sciences Wound Spray Regulatory Class: Unclassified Product Code: FRO Dated: May 17, 2005 Received: May 18, 2005

Dear Dr. Gubish:

This letter corrects our substantially equivalent letter of June 15, 2005.

We have reviewed your Section 510(k) premarket notification of intent to market the We have reviewed your Section 910(x) prematics is substantially equivalent (for the device relevenced above and nave decembly marketed predicate devices marketed
indications for use stated in the enclosure) to the of the Modical Device indicalloris for use stated in the encreases of the enactment and of the Medical Device in in interstate commerce prior to may 20, 1770, and 11 accordance with the provisions of
Amendments or to devices that have been reclassified in accordance corrected of a Amendinents of to devices that ha re over (Act) that do not require approval of a
the Federal Food, Drug, and Cosmetic Act (Act) that do not requires website the the the Federal Food, Drug, and Cosment Act (100), market the device, subject to the general
premarket approval (PMA). You may, therefore, market the Act include prematket approval (1 Mr.). "Totale general controls provisions of the Act include controls provisions of the Act. "The general of devices, good manufacturing practice, the requiremond for anitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III If your device is classified (sec above) into entist regulations affecting your
(PMA), it may be subject to additional controls. Existing major regulations affecting your (PMA), if may be subject to additional controllar controlly of itle 21, Parts 800 to 898. In the Federal device can be found in the Code of Federal Regulations, Courter, Concerning your device in the Federal Register.

3

Page 2 - Edward R. Gubish, Ph.D.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Mark N. Melkerson

Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

4

K042084

Indications for Use

510(k) Number: TBD

Device Name: BioDcrm Sciences Wound Spray

Indications for Use:

BioDcrm Sciences Wound Spray is intended to cleanse, rinsc and externally manage dermal lesions such as lacerations, post-operative (surgical) wounds, partial and full-thickness wounds, burns and ulcers (diabetic, venous stasis, pressure). It may also be used in conjunction with a dressing that absorbs fluids (i.e. gauze, gel, alginate, foam, hydrocolloid).

X Prescription Use (Part 21 CFR 801 Subpart D) Over-the-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

image.png

(Division Sign-Off) Division of General, Restorative and Neurological Devices

510(k) Number K042084

Confidential BioDerm Sciences, Inc.

5

Ko42084

Indications for Use

510(k) Number: TBD

Device Name: BioDerm Sciences Wound Spray

Indications for Use:

BioDerm Sciences Wound Spray is intended to clean, rinse and externally manage skin wounds such as minor lacerations, minor cuts, minor burns and abrasions.

Prescription Use (Part 21 CFR 801 Subpart D) Over-the-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off)
Division of Gene., Restorative

and Neurological Devices

510(k) Number

_特殊 | 上一

Confidential BioDerm Sciences, Inc. 4